$ERAS leads the live board in Mixed Basket with a Factor Residual Spike

🇺🇸 The market’s mixed tone is holding, but $ERAS (Erasca, Inc.) remains the active setup within the basket, signaling a residual spike that could hint at a broader shift. Despite the narrow flow - just 56% breadth - there’s a clear inflow into Healthcare names, with FICO leading the charge. The focus on biotech and healthcare plans underscores a sector-wide interest, but the move is still thin, with follow-through limited so far. Proof lies in the recent residual spike for ERAS, a clinical-stage biotech focused on RAS/MAPK-driven cancers, confirmed by its stable state and the inflow pattern. This suggests that the market is testing the waters for a potential second wave of linked names, especially since most movers are in Healthcare, a sector driven by precision oncology and healthcare plans. The next step is to watch for additional names to confirm a broader shift, with HUM and other linked healthcare stocks as key names to monitor for follow-through.